News Focus
News Focus
icon url

lizzy241

03/07/21 1:37 PM

#328520 RE: ratna1 #328516

ratna, I have contacted an attorney who specializes in SEC matters. She's researching what the possibilities are to form a group of shareholders to submit an additional option in the proxy to either appoint someone to the board or seek out an IB to find a suitor for the company. Zman proposed the idea of initiating rule 14a but not sure if we can implement the proposal in this yrs proxy. There's a time table that must be adhered to for the proposal to be acceptable. The company can easily reject it if not done correctly.
icon url

dukesking

03/07/21 1:41 PM

#328521 RE: ratna1 #328516

Ratna1, I think the most important difference between Amarin selling V, and a well establish BP, is that the BP wouldn’t have the same burden of paying a sales force to sell V, they have a much bigger established sales force in place, and they have well established relationships with all the key players like doctors, PBM’s, and pharmacies etc. A BP may be able to cut the cost of goods enough to lower the price enough to where the generics can’t compete. That’s why I believe a BO is in the works or definitely on the table for serious consideration by big Pharma. It just has to be. My main concern against any near term buyout is the restricted current capacity issue for massive accelerated growth worldwide.
icon url

HinduKush

03/08/21 5:12 AM

#328651 RE: ratna1 #328516

Thanks Ratna,
I agree with your suggestion..after all, we have all seen what concerted mass effort (misguided or otherwise) can do when concertedly applied by the Redditt crowd.."

Can we get a little more a proactive on other issues also as a united special interest shareholder group with some legal framework to be recognized as a united voting block?"